Sasaki and colleagues reported that an increased API5 mRNA expression was detected in 12.7% (12/94) of the non-small cell lung cancer (NSCLC) biopsies and its presence was correlated with poor survival, especially in patients with squamous cell lung cancer [15]. The gene discussed is API5; the disease is squamous cell lung carcinoma.